Nacuity Pharmaceuticals, Inc.
PrivateLast Round
VC Round
Dec 29, 2025
Total Funding Raised
$46.23M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nacuity Pharmaceuticals, Inc. operates in Healthcare & Life Sciences and is based in Fort Worth, Texas. Its latest recorded funding round was a VC Round in December 2025.
Nacuity Pharmaceuticals, Inc. is a biopharmaceutical company that develops targeted antioxidant therapies for the treatment of ocular diseases and serious chronic conditions involving oxidative stress.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nacuity Pharmaceuticals, Inc. Comparables
Compare Nacuity Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kyoto Drug Discovery & Development Co., Ltd. | 76% | |
| Kiora Pharmaceuticals | 76% | |
| Aldeyra Therapeutics | 76% |
For institutional investors. Book with your work email.
Nacuity Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 29, 2025 | ||||
| Series B | Jun 15, 2022 | ||||
| Series A Extension | Jan 3, 2022 | ||||
| VC Round | Mar 30, 2021 | ||||
| Series A | Jan 24, 2019 | ||||
Series A | Jan 19, 2017 |
For institutional investors. Book with your work email.
Nacuity Pharmaceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Johns Hopkins Technology Ventures | Series A |
| Tarnagulla Ventures | Series A |
| Foundation Fighting Blindness | Series B, Series A, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 39% MoM, from 2.7K to 3.7K.
- Dec 29, 2025
$13M round led by Foundation Fighting Blindness.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- licenses_technologyOct 22, 2026
Nacuity Pharmaceuticals, Inc. licenses AT-001, a formulation of N-acetylcysteine amide, to Arctic Therapeutics.
For institutional investors. Book with your work email.
Nacuity Pharmaceuticals, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nacuity Pharmaceuticals, Inc.'s valuation, stock price, and market status.
Is Nacuity Pharmaceuticals, Inc. a public or private company?
Nacuity Pharmaceuticals, Inc. is a private company.
What is the current stock price of Nacuity Pharmaceuticals, Inc.?
Nacuity Pharmaceuticals, Inc. is a private company, so its shares have no public market price. Caplight tracks Nacuity Pharmaceuticals, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nacuity Pharmaceuticals, Inc. worth (valuation)?
Valuation information for Nacuity Pharmaceuticals, Inc. is not publicly available.
Can I buy Nacuity Pharmaceuticals, Inc. stock?
Nacuity Pharmaceuticals, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nacuity Pharmaceuticals, Inc.'s last funding round?
Nacuity Pharmaceuticals, Inc.'s most recent funding round was VC Round on December 29, 2025.
Who are the main investors in Nacuity Pharmaceuticals, Inc.?
Key investors in Nacuity Pharmaceuticals, Inc. include Foundation Fighting Blindness.
Will Nacuity Pharmaceuticals, Inc. IPO soon?
No public IPO plans have been announced for Nacuity Pharmaceuticals, Inc..
How can I track Nacuity Pharmaceuticals, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Nacuity Pharmaceuticals, Inc.'s shares on secondary markets.